[Variations in the behavior in chronic hospitalized schizophrenics under treatment with EMD 16, 139, a benzoquinolizine derivative].
A group of hospitalized chronic schizophrenic patients was treated with EMD 16 139 - a benzochinolizin derivate - for 4 weeks in a placebo-controlled trial. Changes of behavior were measured using a rating scale. The results suggest an increase of activity and initiative during treatment. Problems concerning some neuroleptic effects are discussed.